Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
245 participants
INTERVENTIONAL
2023-12-11
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
1. Can C-mo System detect cough events? (automatic cough detection)
2. Can C-mo System characterise cough events? (calculation of cough intensity, identification of cough type and presence of wheeze in detected coughs)
Participants will be asked to:
* Wear the C-mo Wearable device for 24 hours (1 day);
* Complete a diary with relevant activities throughout the monitoring period;
* Fill-out questionnaires related to coughing frequency and intensity, usability of the device, and impact of cough on quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cough Monitoring in COPD
NCT07098793
Clinical Validation of the Hyfe Cough Monitoring System
NCT05723159
Validation of a Questionnaire to Measure Cough Severity
NCT06669897
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00722267
Cough Frequency in Chronic Obstructive Pulmonary Disease
NCT01405222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
C-mo System
C-mo System
Patients will use C-mo System for a period of 24h, to assess cough characteristics.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C-mo System
Patients will use C-mo System for a period of 24h, to assess cough characteristics.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with symptoms/complaints of cough;
* Signed Informed Consent (age ≥ 18 years), signed Informed Consent from the parents/legal representative and the patient (16 and 17 years), or signed Informed Assent and Consent (5 years ≤ age ≤ 15 years).
Exclusion Criteria
* Damaged/weakened skin at the C-mo wearable device's placement area (epigastric region).
* Absence of Informed Consent and/or Assent, as applicable.
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Nova de Lisboa
OTHER
Cough Monitoring Medical Solutions
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nuno M Neuparth, PhD
Role: PRINCIPAL_INVESTIGATOR
NOVA Medical School | Faculdade de Ciências Médicas da Universidade Nova de Lisboa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HPAV - Trofa Saúde Hospital de Alfena
Alfena, , Portugal
HFF - Hospital Professor Doutor Fernando Fonseca
Amadora, , Portugal
Lab3R - Laboratório de Investigação e Reabilitação Respiratória da Escola Superior de Saúde da Universidade de Aveiro
Aveiro, , Portugal
CHUC - Centro Hospitalar e Universitário de Coimbra
Coimbra, , Portugal
HDE - Hospital Dona Estefânia
Lisbon, , Portugal
NMS Research - Laboratório de Exploração Funcional | Fisiopatologia
Lisbon, , Portugal
CHUSJ - Centro Hospitalar Universitário de São João
Porto, , Portugal
ICUFP - Instituto CUF Porto
Porto, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Daniela Rodrigues
Role: primary
José Pedro Boléo-Tomé
Role: primary
Ana Oliveira
Role: primary
Pedro Gonçalo Ferreira
Role: primary
Raquel Lopes de Bragança
Role: primary
Nuno Neuparth
Role: primary
David Araújo
Role: primary
João Carlos Winck
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-mo_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.